SCHEMBL30846439

SCHEMBL30846439

CCOC(=O)c1cnc(Cl)c([N+](=O)[O-])c1Cl

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.46
MAPT P10636 4/20 0.44
KDM4E B2RXH2 5/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
POLB P06746 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 3/20 0.41
HSP90AA1 P07900 2/20 0.41
GALR2 O43603 1/20 0.41
MITF O75030 1/20 0.41
LMNA P02545 1/20 0.41
XBP1 P17861 1/20 0.41
CCR6 P51684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574989 1.00 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL27314724 0.89 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL4497497 0.86 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL14031475 0.86 ALDH1A1 (0.47) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL3216900 0.85 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL14468617 0.84 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL14543449 0.84 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL4766494 0.84 ALDH1A1 (0.46) ALDH1A1KMT2AMEN1MAPTKDM4E
SCHEMBL4718816 0.84 SMN1; SMN2 (0.41) ALDH1A1KMT2AMEN1MAPTPOLB
SCHEMBL24455485 0.83 ALDH1A1 (0.45) ALDH1A1KMT2AMEN1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 EP disclosed
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 WO disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 WO disclosed